| Series Preface |
|
ix | |
| Preface |
|
xi | |
| Acknowledgments |
|
xiii | |
| About the Editors |
|
xv | |
| Contributors |
|
xvii | |
|
PART I Physical Basis of Magnetic Resonance Imaging |
|
|
|
1 The Biology and Imaging of Cancer |
|
|
|
|
|
3 | (4) |
|
|
|
|
|
|
7 | (1) |
|
Uncontrolled Cellular Growth |
|
|
|
|
|
|
|
|
|
1.3 Classification of Tumors |
|
|
8 | (1) |
|
|
|
|
1.4 Cancer Imaging Modalities and Strategies |
|
|
8 | (9) |
|
|
|
|
|
|
|
|
|
|
Nuclear Imaging (Scintigraphy, PET, and SPECT) |
|
|
|
Magnetic Resonance Imaging |
|
|
|
|
|
|
|
|
|
|
|
|
Future Prospects for Developments in Cancer Imaging |
|
|
|
|
|
12 | (5) |
|
|
|
17 | (10) |
|
|
|
|
|
17 | (1) |
|
2.2 Description of Magnetization |
|
|
17 | (3) |
|
2.3 Rotating Reference Frame |
|
|
20 | (1) |
|
2.4 Definition of Magnetization |
|
|
21 | (1) |
|
|
|
21 | (3) |
|
Longitudinal Relaxation: T1 |
|
|
|
Transverse Relaxation: T2 |
|
|
|
|
|
|
2.6 Mathematical Formalism for Relaxation: Bloch Equations |
|
|
24 | (1) |
|
2.7 Formation of an Observable Quantity: Signal |
|
|
24 | (1) |
|
2.8 Final Thoughts: From Signal to Image |
|
|
25 | (1) |
|
|
|
26 | (1) |
|
|
|
26 | (1) |
|
3 Magnetic Resonance Imaging: Hardware and Data Acquisition |
|
|
27 | (12) |
|
|
|
3.1 Magnets and Magnet Structures |
|
|
28 | (3) |
|
B0 Inhomogeneity Compensation |
|
|
|
Siting and Magnetic Shielding |
|
|
|
|
|
|
|
|
31 | (1) |
|
|
|
31 | (1) |
|
|
|
|
|
|
32 | (3) |
|
Requirements for RF Systems |
|
|
|
RF Transmitters (B1) Systems |
|
|
|
|
|
|
RF Transmission Technology |
|
|
|
Sampling of Received Signals |
|
|
|
|
|
|
Linear versus Quadrature Coils |
|
|
|
|
|
|
|
|
|
|
|
35 | (1) |
|
|
|
|
RF Burns from Current Loops |
|
|
|
|
|
|
Peripheral Nerve Stimulation |
|
|
|
|
|
|
|
|
|
|
|
36 | (3) |
|
|
|
37 | (2) |
|
|
|
39 | (14) |
|
|
|
|
|
39 | (1) |
|
4.2 Description of Image Formation |
|
|
40 | (1) |
|
|
|
40 | (2) |
|
|
|
|
|
|
|
|
|
42 | (2) |
|
|
|
|
|
|
|
|
|
|
Extensions to Three Dimensions |
|
|
|
4.5 K-Space and Pulse Sequences |
|
|
44 | (3) |
|
|
|
|
|
|
|
|
|
47 | (6) |
|
|
|
|
Parallel Imaging and Reconstruction |
|
|
|
|
|
50 | (3) |
|
PART II Characterizing Tissue Properties with Endogenous Contrast Mechanisms |
|
|
|
5 Quantitative Measurement of T1, T2, T2*, and Proton Density |
|
|
53 | (14) |
|
|
|
|
|
|
|
53 | (1) |
|
5.2 NMR Relaxation in Cancerous Tissue |
|
|
53 | (2) |
|
Biophysical Basis of Relaxation Time Changes |
|
|
|
Multiexponential Relaxation |
|
|
|
|
|
|
5.3 Pulse Sequences and Signal Equations |
|
|
55 | (1) |
|
5.4 Spin-Spin Relaxation (T2) |
|
|
56 | (3) |
|
|
|
|
Optimization of Acquisition Parameters |
|
|
|
|
|
|
|
|
|
|
|
|
5.5 Effective Spin--Spin Relaxation (T2*) |
|
|
59 | (2) |
|
|
|
|
Optimization of Acquisition Parameters |
|
|
|
|
|
|
5.6 Spin-Lattice Relaxation (T1) |
|
|
61 | (2) |
|
Saturation and Inversion Recovery |
|
|
|
Variable Flip Angle Gradient Echo |
|
|
|
Optimization of Acquisition Parameters |
|
|
|
|
|
|
5.7 Proton Spin Density (M0) |
|
|
63 | (1) |
|
|
|
63 | (4) |
|
|
|
63 | (4) |
|
6 Arterial Spin Labeling Techniques |
|
|
67 | (14) |
|
|
|
|
|
|
|
67 | (1) |
|
|
|
67 | (1) |
|
|
|
68 | (5) |
|
|
|
|
|
|
|
|
|
73 | (4) |
|
Description of Quantitative ASL Models |
|
|
|
Issues Affecting Quantification |
|
|
|
|
|
|
Issues Affecting Quantification: Physiologically Based |
|
|
|
6.5 ASL in Cancer Biology Studies |
|
|
77 | (1) |
|
Tumor Diagnosis and Characterization |
|
|
|
|
|
|
|
|
78 | (3) |
|
|
|
78 | (3) |
|
|
|
81 | (18) |
|
|
|
|
|
|
|
81 | (1) |
|
7.2 Biological Basis of DW-MRI |
|
|
81 | (1) |
|
7.3 Diffusion-Weighted MRI |
|
|
82 | (2) |
|
7.4 Practical Considerations |
|
|
84 | (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
90 | (2) |
|
|
|
|
|
|
|
|
|
92 | (7) |
|
|
|
|
|
|
|
|
|
93 | (1) |
|
|
|
93 | (6) |
|
8 Magnetization Transfer and Chemical Exchange Saturation Transfer Imaging in Cancer Imaging |
|
|
99 | (8) |
|
|
|
|
|
8.1 Magnetization Transfer |
|
|
99 | (3) |
|
Qualitative Description of MT |
|
|
|
Quantitative Description of MT |
|
|
|
|
|
|
Transfer versus Relaxation |
|
|
|
|
|
|
8.2 Chemical Exchange Saturation Transfer |
|
|
102 | (2) |
|
Qualitative Description of CEST |
|
|
|
Quantitative Description of CEST |
|
|
|
|
|
|
|
|
104 | (3) |
|
|
|
104 | (3) |
|
9 MR Spectroscopy and Spectroscopic Imaging of Tumor Physiology and Metabolism |
|
|
107 | (18) |
|
|
|
|
|
|
|
|
|
|
|
107 | (1) |
|
9.2 Qualitative Introduction to MRS Techniques |
|
|
107 | (3) |
|
9.3 Quantitative Introduction to MRS Techniques |
|
|
110 | (2) |
|
1H Magnetic Resonance Spectroscopy |
|
|
|
31P MRS, 19F MRS, and 13C MRS |
|
|
|
|
|
|
9.4 Preclinical Applications in Cancer |
|
|
112 | (3) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delivery and Treatment Efficacy |
|
|
|
|
|
|
Hyperpolarization, A New Research Area |
|
|
|
9.5 Applications in Cancer Diagnosis |
|
|
115 | (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
9.6 Clinical Applications in Cancer Therapy |
|
|
116 | (1) |
|
Drug Delivery Visualization |
|
|
|
Planning Treatment and Monitoring Treatment Response |
|
|
|
9.7 Extensions to Fields >3 T |
|
|
117 | (8) |
|
|
|
118 | (1) |
|
|
|
118 | (7) |
|
PART III Characterizing Tissue Properties with Exogenous Contrast Agents |
|
|
|
10 Contrast Agents for T1-Weighted MRI |
|
|
125 | (10) |
|
|
|
|
|
|
|
|
|
|
|
125 | (1) |
|
10.2 Complexes of Gadolinium |
|
|
126 | (3) |
|
10.3 Effect of Chelators on Metal-Water Interactions |
|
|
129 | (1) |
|
|
|
129 | (2) |
|
Macromolecules: Linear Species |
|
|
|
Macromolecules: Nonlinear Species |
|
|
|
Macromolecules: Protein/Saccharide Carriers |
|
|
|
Macromolecules: "Smart" Agents |
|
|
|
|
|
131 | (1) |
|
|
|
131 | (4) |
|
|
|
131 | (4) |
|
11 Nanoparticles for T2-and T2*-Weighted MRI |
|
|
135 | (8) |
|
|
|
|
|
|
|
135 | (1) |
|
11.2 Design and Use of T2 Contrast Agents |
|
|
135 | (2) |
|
11.3 Targeted Nanopartieles for T2-Weighted Imaging |
|
|
137 | (1) |
|
11.4 Nanomedicine and Treatment Applications |
|
|
138 | (1) |
|
|
|
139 | (1) |
|
|
|
139 | (4) |
|
|
|
139 | (4) |
|
12 Dynamic Contrast-Enhanced MRI: Data Acquisition and Analysis |
|
|
143 | (20) |
|
|
|
|
|
12.1 Qualitative Introduction |
|
|
143 | (1) |
|
|
|
|
Overview of Dynamic Contrast-Enhanced MRI |
|
|
|
12.2 Quantitative Introduction |
|
|
144 | (5) |
|
|
|
|
|
|
|
|
|
|
|
|
|
12.3 Peclinical Applications in Cancer |
|
|
149 | (4) |
|
Early Drug Efficacy Studies: iAUC |
|
|
|
Early Drug Efficacy Studies: Tofts |
|
|
|
Early Drug Efficacy Studies: Extended Tofts |
|
|
|
Studying Tumor Microenvironment |
|
|
|
12.4 Application in Cancer Diagnosis |
|
|
153 | (2) |
|
|
|
|
|
|
|
|
|
|
12.5 Application in Cancer Therapy |
|
|
155 | (2) |
|
Longitudinal Monitoring of Treatment Response in Breast |
|
|
|
Longitudinal Monitoring of Treatment Response in Brain |
|
|
|
Longitudinal Monitoring of Treatment Response in Prostate |
|
|
|
12.6 Extensions to Fields>3 T |
|
|
157 | (6) |
|
|
|
157 | (6) |
|
13 Dynamic Susceptibility MRI: Data Acquisition and Analysis |
|
|
163 | (14) |
|
|
|
13.1 Qualitative Introduction to Dynamic Susceptibility Contrast MRI |
|
|
163 | (1) |
|
13.2 Quantitative Introduction to DSC-MRI |
|
|
164 | (8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13.3 Preclinical Applications in Cancer |
|
|
172 | (1) |
|
13.4 DSC-MRI Applications in Cancer Diagnosis |
|
|
172 | (1) |
|
13.5 DSC-MRI Applications in Cancer Therapy |
|
|
173 | (1) |
|
13.6 Extensions to Fields>3 T |
|
|
174 | (1) |
|
|
|
174 | (3) |
|
|
|
174 | (3) |
|
14 Magnetic Resonance Angiography |
|
|
177 | (16) |
|
|
|
|
|
|
|
|
|
177 | (1) |
|
14.2 Basics of MRI and Motion |
|
|
177 | (1) |
|
14.3 Non--Contrast-Enhanced MRA |
|
|
178 | (6) |
|
|
|
|
Two-Dimensional Time-of-Flight MRA |
|
|
|
Three-Dimensional Time-of-Flight MRA |
|
|
|
Steady-State Free Precession Sequences |
|
|
|
|
|
|
14.4 Contrast-Enhanced MRA |
|
|
184 | (2) |
|
Three-Dimensional Contrast-Enhanced MRA |
|
|
|
|
|
|
14.5 Preclinical Applications |
|
|
186 | (2) |
|
14.6 Clinical Applications |
|
|
188 | (1) |
|
14.7 MRA at Field Strengths>3 T |
|
|
189 | (1) |
|
|
|
189 | (4) |
|
|
|
189 | (4) |
|
PART IV Image Processing in Cancer |
|
|
|
15 Imaging Tissue Oxygenation Status with MRI |
|
|
193 | (10) |
|
|
|
|
|
15.1 Qualitative Introduction to MR Imaging of Tissue Oxygenation |
|
|
194 | (1) |
|
|
|
|
|
|
|
15.2 Quantitative Introduction to MR Imaging of Tissue Oxygenation |
|
|
194 | (4) |
|
Fluorine MRI: PFC Selection and Administration |
|
|
|
|
|
|
|
|
|
15.3 Preclinical Applications in Cancer |
|
|
198 | (1) |
|
|
|
|
|
|
|
15.4 Clinical Applications in Cancer |
|
|
199 | (1) |
|
|
|
200 | (3) |
|
|
|
200 | (3) |
|
16 Clinical Assessment of the Response of Tumors to Treatment with MRI |
|
|
203 | (10) |
|
|
|
16.1 Approach to Tumor Treatment Response Assessment |
|
|
203 | (2) |
|
16.2 Cancer Response Criteria |
|
|
205 | (2) |
|
History of Cancer Response Criteria |
|
|
|
Detailed Example of RECIST 1.1 Criteria |
|
|
|
16.3 Requirements for the Development of MRI-Based Cancer Response Criteria |
|
|
207 | (2) |
|
|
|
|
|
|
|
Correlation of Changes in Tumor Burden with Clinical Endpoints |
|
|
|
Validation of Response Criteria |
|
|
|
16.4 Biomedical Informatics Systems to Support Treatment Response Assessment |
|
|
209 | (4) |
|
|
|
|
|
|
|
Automated Response Interpretation Methods |
|
|
|
|
|
210 | (1) |
|
|
|
210 | (3) |
|
|
|
213 | (24) |
|
|
|
|
|
|
|
17.1 Qualitative Introduction to Segmentation Techniques for MRI |
|
|
214 | (2) |
|
Data-Driven Techniques (Bottom-Up) |
|
|
|
Model-Driven Techniques (Top-Down) |
|
|
|
Hybrid Techniques (Low, Mid, and High Level) |
|
|
|
17.2 Quantitative Introduction to Segmentation Techniques for MRI |
|
|
216 | (7) |
|
|
|
|
|
|
|
|
|
|
17.3 Preclinical Applications in Cancer |
|
|
223 | (3) |
|
Tumor Assessment Using Bottom-Up Methods |
|
|
|
|
|
|
|
|
|
Organ Segmentation Using Top-Down Methods |
|
|
|
17.4 Applications in Clinical Cancer Diagnosis |
|
|
226 | (2) |
|
|
|
|
|
|
|
17.5 Applications in Clinical Cancer Therapy |
|
|
228 | (3) |
|
|
|
|
|
|
|
Model-Based Approaches for Cancer Therapy |
|
|
|
|
|
231 | (6) |
|
|
|
231 | (6) |
|
18 Spatial and Temporal Image Registration |
|
|
237 | (14) |
|
|
|
18.1 Qualitative Introduction to Image Registration |
|
|
237 | (1) |
|
18.2 Quantitative Introduction to Image Registration |
|
|
238 | (7) |
|
|
|
|
Point-Based Registration Methods |
|
|
|
|
|
|
|
|
|
Intensity-Based Registration Methods |
|
|
|
18.3 Preclinical Applications in Cancer |
|
|
245 | (1) |
|
18.4 Clinical Applications in Cancer |
|
|
245 | (1) |
|
|
|
246 | (5) |
|
|
|
247 | (1) |
|
|
|
247 | (4) |
|
19 Synthesis of Multiparametric Data |
|
|
251 | (14) |
|
|
|
|
|
|
|
|
|
251 | (1) |
|
19.2 Methods for Multiparameter Mapping |
|
|
251 | (4) |
|
|
|
|
Statistically Based Methods |
|
|
|
19.3 Applications in Cancer |
|
|
255 | (4) |
|
Preclinical Applications in Cancer |
|
|
|
Applications in Cancer Diagnosis |
|
|
|
Applications in Cancer Therapy |
|
|
|
|
|
259 | (6) |
|
|
|
259 | (6) |
|
|
|
|
20 MRI in Radiation Therapy Planning |
|
|
265 | (12) |
|
|
|
|
|
|
|
|
|
|
|
20.1 Qualitative Introduction to Technique |
|
|
265 | (1) |
|
20.2 Quantitative Introduction to Techniques of Quality Assurance of Image Registration |
|
|
266 | (2) |
|
20.3 Applications in Cancer Diagnosis |
|
|
268 | (1) |
|
20.4 Applications in Cancer Therapy |
|
|
268 | (4) |
|
|
|
|
MRI in the Management of Brain Tumors |
|
|
|
|
|
|
Response to Radiotherapy Treatment in HNSCC |
|
|
|
MR Detects Changes in Pharyngeal Constrictors to Radiation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
272 | (5) |
|
|
|
273 | (4) |
|
21 Molecular and Cellular Imaging |
|
|
277 | (12) |
|
|
|
|
|
277 | (6) |
|
Design and Testing of MRI Molecular Imaging Agents |
|
|
|
Types of Molecular Imaging Agents |
|
|
|
Future Developments and Refinements |
|
|
|
|
|
283 | (2) |
|
|
|
|
|
|
|
|
|
|
Imaging of Superparamagnetic Cells |
|
|
|
Limitations of Cell Labeling |
|
|
|
Recent Advances in Cell Labeling |
|
|
|
Alternative Cell Labeling Approaches |
|
|
|
Cellular Imaging of Cancer |
|
|
|
|
|
285 | (4) |
|
|
|
285 | (1) |
|
|
|
285 | (4) |
|
22 Hyperpolarized MR of Cancer |
|
|
289 | (14) |
|
|
|
|
|
22.1 Qualitative Introduction to Hyperpolarized Imaging Techniques |
|
|
289 | (4) |
|
Introduction to Thermal Polarization of Conventional MR and Hyperpolarization Techniques of MR Signal Enhancement |
|
|
|
Sensitivity Enhancement by Hyperpolarization |
|
|
|
|
|
|
Fundamentals of PASADENA and PHIP |
|
|
|
|
|
|
Xenon (129Xe)-Induced Polarization (XIP) |
|
|
|
22.2 Hyperpolarized MR Detection |
|
|
293 | (2) |
|
Decay of MR Hyperpolarization |
|
|
|
MR Detection of Hyperpolarization |
|
|
|
22.3 Preclinical Applications |
|
|
295 | (4) |
|
Metabolic Contrast Agents |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22.4 Applications in Cancer Therapy |
|
|
299 | (4) |
|
Monitor the Efficacy of Chemotherapy, Gene Therapy, and Radiation Therapy |
|
|
|
Comparison with PET and Clinical Translation Perspectives |
|
|
|
|
|
299 | (4) |
| Index |
|
303 | |